Skip to main content

Table 1 Details of graft, cell dosing, and graft assessment plan

From: iPSC-derived MSC therapy induces immune tolerance and supports long-term graft survival in mouse orthotopic tracheal transplants

Donor

Recipient

Treatment

Group purpose

Assessments (d)

C57BL/6

C57BL/6

Saline

Saline-treated syngeneic control

8–14, 20, 28, 90

BALB/c

C57BL/6

Saline

Saline-treated allogeneic control

8–14, 20, 28, 90

BALB/c

C57BL/6

iPSC-derived MSCs

To test the efficacy of iPSC-derived MSCs

8–14, 20, 28, 90

  1. Sample size (n) = 12–18 transplants/time points/experiment